Popular Articles
Cellulite Treatment

New Support For A Controversial Mechanism Underlying An Irregular Heart Beat
The most common form of human heart beat irregularity (atrial fibrillation) can be fatal if left untreated. It has been suggested that it is caused, in part, by calcium leaking from a cellular store in heart cells, potentially through the RyR2 channel, although this mechanism remains controversial. However, a team of researchers at Baylor College of Medicine, Houston, and Dresden University of Technology, Germany, has provided support for this hypothesis by showing that the protein CaMKII can enhance RyR2-mediated calcium leak, promoting atrial fibrillation in mice.
generic viagra online
Addex Partner Starts First-Ever Clinical Trial Of An MGluR Positive Allosteric Modulator
Allosteric modulation company Addex Pharmaceuticals (SWISS: ADXN) announced today that its partner Ortho-McNeil- Janssen Pharmaceuticals Inc. (OMP) has started Phase I testing of ADX71149, a metabotropic glutamate receptor 2 (mGluR2) positive allosteric modulator (PAM). This product, which has potential to treat schizophrenia, anxiety, depression and other CNS disorders, is the first PAM of any mGluR subtype to enter clinical trials. Targeting mGluR2 with a PAM is a novel approach that may offer advantages over classical drug approaches. In reaching this milestone, Addex received a EUR 1 million payment from OMP and remains eligible for additional development milestones and royalties.
News of the day
BioCis Pharma Starts A Phase I Clinical Trial With A New Cancer Drug
BioCis Pharma Ltd., a privately-held drug development company with its headquarters in Turku, Finland, has started Phase I clinical testing of ProtoCure(TM) intravesical instillation solution, a novel anti-cancer drug for urinary bladder cancer. ProtoCure is based on a new mechanism of action discovered and developed by BioCis Pharma which effectively prevents cancer growth and proliferation locally.
Public Health

When Adult Patients Have Anxiety Disorder, Their Children Need Help Too

In what is believed to be the first U.S. study designed to prevent anxiety disorders in the children of anxious parents, researchers at the Johns Hopkins Children"s Center have found that a family-based program reduced symptoms and the risk of developing an anxiety disorder among these children. Despite its small size, the study suggests that as few as eight weekly family sessions of cognitive behavioral therapy go a long way to prevent or minimize the psychological damage of childhood anxiety. Results of the study will appear in the June issue of the Journal of Consulting and Clinical Psychology. "If psychiatrists or family doctors diagnose anxiety in adult patients, it"s now clearly a good idea that they ask about the patients" children and, if appropriate, refer them for evaluation," says senior investigator Golda Ginsburg, Ph.D., a child psychologist at Hopkins Children"s and associate professor of psychiatry at the Johns Hopkins School of Medicine. "Right now, most doctors don"t think about this, let alone broach the subject." Ginsburg says data show that the children of parents diagnosed with an anxiety disorder are up to seven times more likely to develop an anxiety disorder themselves, and up to 65 percent of children living with an anxious parent meet criteria for an anxiety disorder. Prevention, rather than treatment, of childhood anxiety is critical because anxiety disorders affect one in five U.S. children but often go unrecognized, according to a recent editorial in The New England Journal of Medicine. Delay in diagnosis and treatment can lead to depression, substance abuse and poor academic performance throughout childhood and well into adulthood. The Hopkins team studied 40 children between 7 and 12 not diagnosed with anxiety themselves but who had one or both parents diagnosed with an anxiety disorder. Half of the children and their families were enrolled in an eight-week cognitive behavioral therapy, while the other half were put on a waiting list and received no therapy at the time of the study, but were offered therapy a year later. The program, consisting of hour-long weekly sessions was designed to help parents identify and change behaviors believed to contribute to anxiety in the children, while at the same time teaching children coping and problem-solving skills. Within a year, 30 percent of the children in the no-intervention group had developed an anxiety disorder, compared to none of the children who participated in the family-based therapy. Parents along with researchers who evaluated the children and their parents independently reported a 40-percent drop in anxiety symptoms in the year following the prevention program. There was no reduction of anxiety symptoms among children on the waiting list. The parental behaviors modified with treatment included overprotection, excessive criticism and excessive expression of fear and anxiety in front of the children. The program targeted such childhood risk factors as avoiding anxiety-provoking situations and anxious thoughts. The Hopkins Children"s team is now conducting a larger study involving 100 families. The research was funded by the National Institute of Mental Health. Ekaterina Pesheva Johns Hopkins Medical Institutions


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):